Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 1363 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Ottobock–Steeper: prosthetic, 201702 acquisition of BeBionic hand product range by Ottobock from Steeper 2017-02-02
Rentschler–Leukocare: drug formulation technology, 201702– collab strategic alliance using SPS technology for biopharmaceuticals 2017-02-02
Immunic–Saxony-Anhalt (govt): investment, 201702 investment Series A €4m by new investor IBG bringing total to €21.7m 2017-02-01
Regeneron–Indivumed: tissue banking, 201701– collab + supply €na tissue samples w clinical + molecular data for cancer research 2017-01-31
Medizinsches Labor Bremen–Sonic Healthcare: investment, 201701– acquisition for €63m (cash + debt free) of MLB by Sonic Healthcare Ltd 2017-01-30
ProteomeTools project–BioNTech: proteomics, 201701 collab existent JPM Peptide Technologies is project partner 2017-01-30
ProteomeTools project–SAP: proteomics, 201701 collab existent SAP is project partner 2017-01-30
ProteomeTools project–Thermo Fisher: proteomics, 201701 collab existent Thermo Fisher Scientific is project partner 2017-01-30
ProteomeTools project–TU Munich: proteomics, 201701 collab existent TUM is coordinating project partner in developing PROPEL library 2017-01-30
Sonic Healthcare–McDermott Will & Emery: legal services, 201701 adviser for acquisition of Medical Lab Bremen by Sonic Healthcare Ltd 2017-01-30
United Kingdom (govt)–Qiagen: genomic database, 201701– Genomics England to use HGMD Online Professsional solution for 100,000 Genomes Project 2017-01-30
Merck (DE)–Domain Therapeutics: cancer drugs, 201701– collab developm + ww license to adenosine receptor antagonists 2017-01-23
Affimed–SEVERAL: investment, 201701 public offering $18m ($16.6m net) with 10m+1.5m common shares at $1.8/share 2017-01-19
Asahi Kasei–Evotec: drug discovery, 201701– supply service €na expansion into integrated drug discovery collab for inhibitors of ion channel targets 2017-01-19
Fibrocor Therapeutics–Evotec: drug discovery services, 201701– collab developm fibrosis drugs w all drug discovery activities done by Evotec 2017-01-17
Fibrocor Therapeutics–Evotec: investment, 201701 Evotec to receive equity stake in Fibrocor as part of collaboration 2017-01-17
Mologen–SEVERAL: credit, 201701–202501 convertible bonds €4.99m at 6% incl major shareholder GTD 2017-01-17
Northwell Health–Indivumed: tissue bank, 201701– collab to create cancer research biobank 2017-01-17
Luxendo–Huntsworth: public relations, 201701 service existent by Citigate Dewe Rogerson 2017-01-12
Luxendo–SEVERAL: investment, 201701 financing round Series A extension €2m bringing total to €8m co-led by LSP + EMBL Ventuers + EMBLEM 2017-01-12
MorphoSys–JPMorgan Chase: investor conference, 201701 supply service MorphoSys presents at JP Morgan Healthcare Conference 2017 2017-01-12
Amgen–Immatics: cancer immunotherapy, 201701– strategic collab $30m upfront + $500m milestones + royalties combining Xpresident + BiTE technologies 2017-01-09
CureVac–JPMorgan Chase: investor conference, 201701 supply service CureVac presents at JP Morgan Healthcare Conference 2017 2017-01-09
Eternygen–Berlin (govt): investment, 201701 financing round Series A totalling €8m incl co-investor VC Fonds Technologie managed by IBB 2017-01-09
Eternygen–Epidarex Capital: investment, 201701 financing round Series A totalling €8m incl lead investor Epidarex Capital 2017-01-09
Eternygen–Evotec: investment, 201701 financing round Series A totalling €8m incl co-investor Evotec AG 2017-01-09
Eternygen–MC Services: public relations, 201701 service existent by MC Services AG 2017-01-09
Eternygen–SEVERAL: investment, 201701 financing round Series A €8m led by Epidarex Capital plus Evotec + VC Fonds Technologie + 2 family offices et al 2017-01-09
HepaRegenix–Boehringer: investment, 201701 financing round Series A totalling €9m co-led by BIVF + Novo Seeds + incl HTGF + Coparion 2017-01-05
HepaRegenix–Germany (govt): investment, 201701 financing round Series A totalling €9m co-led by BIVF + Novo Seeds + incl HTGF + Coparion 2017-01-05
HepaRegenix–High-Tech Gründerfonds: investment, 201701 financing round Series A totalling €9m co-led by BIVF + Novo Seeds + incl HTGF + Coparion 2017-01-05
HepaRegenix–MC Services: public relations, 201701 service existent by MC Services AG 2017-01-05
HepaRegenix–Novo Group: investment, 201701 financing round Series A totalling €9m co-led by BIVF + Novo Seeds + incl HTGF + Coparion 2017-01-05
HepaRegenix–SEVERAL: investment, 201701 financing round Series A €9m co-led by BIVF + Novo Seeds + incl HTGF + Coparion 2017-01-05
Affimed–Univ Texas: cancer immunotherapy, 201701– collab clinical + commerc to evalaute TandAbs with natural killer cell product of MD Anderson 2017-01-04
AiCuris–MC Services: public relations, 201701 service existent by MC Services AG Düsseldorf 2017-01-04
Aptarion Biotech–Noxxon: investment, 201701 Noxxon receives Aptarion shares as part of transfer of preclinical assets to Aptarion 2017-01-04
Aptarion Biotech–Noxxon: Spiegelmer technology, 201701 acquisition techn + preclinical assets + lab assets from Noxxon for cash + royalties + shares 2017-01-04
BioControl Systems–Merck (DE): investment, 201701 acquisition €na of BioControl Systems Inc by Merck KGaA 2017-01-04
InVivo Biotech Services–Bruker Corp: investment, 201701 acquisition €na of InVivo Biotech Services GmbH by Bruker 2017-01-04
SCiLS GmbH–Bruker Corp: investment, 201701 acquisition €na of SCiLS GmbH by Bruker 2017-01-04
Bio-ITech–Eppendorf: investment, 2017Q1 acquisition of majority share in Bio-ITech BV by Eppendorf 2017-01-01
dKK GmbH–Bavaria (govt): science/business park services, 201704– supply serivce dKK GmbH Martinried is new tenant at IZB Martinsried 2017-01-01
Immunic–Bavaria (govt): science/business park services, 201701– supply service Immunic AG is new tenant at IZB Martinsried 2017-01-01
Ridgeway Biologicals–Klocke: investment, 201701 acquisition of Ridgeway Biologicals by IDT Biologika 2017-01-01
SciMab–Bavaria (govt): science/business park services, 201701– supply serivce SciMab GmbH is new tenant at IZB Martinsried 2017-01-01
C.B.S. Scientific–Genetrix (ES): investment, 201612 acquisition $900k of C.B.S. Scientific Company for $540k cash + $360k in shares by Sygnis AG 2016-12-21
Bluebird Bio–Apceth: contract manufacturing, 201612– collab strategic European manufacturing of Lenti-D + LentiGlobin by Apceth Biopharma GmbH 2016-12-15
Acousia Therapeutics–SEVERAL: investment, 201612 financing round €2.5m led by BIVF + incl KfW + Axxam 2016-12-14
Amcure–SEVERAL: investment, 201612 financing round Series B €6m led by LBBW Venture Capital GmbH 2016-12-14
Gilupi–Viroad: investment, 201612 acquisition of remaining shares in Gilupi by Viroad after becoming largest shareholder in 2012 2016-12-14
Carpegen–Lifescience Business Consulting: business cosulting, 201612 supply portfolio/market analysis for sale of Gyronimo RT-PCR platform to Curetis 2016-12-13
Carpegen–Osborne Clarke: legal services, 201612 supply legal adviser for sale of Carpegen’s Gyronimo RT-PCR platform to Curetis 2016-12-13
Carpegen–Systec Elektronik: real-time PCR technology, 201612 collab existent development of Gyronimo platform co-owned by Carpegen + Systec 2016-12-13
Curetis–Carpegen: real-time PCR technology, 201612 acquisition €5m cash + €2.5m+€9m milestones of Gyronimo platform from Carpegen + Systec 2016-12-13
BlueRock Therapeutics–Bayer: investment, 201612– financing round Series A totalling of $225m committed by Bayer + Versant Ventures 2016-12-12
Forge Therapeutics–Evotec: drug discovery services, 201612– collab strategic alliance lead optimisation of LpxC inhibitors by Evotec 2016-12-09
Numares–Ruth Group: public relations, 201612 service existent US PR + IR by The Ruth Group 2016-12-08
Genetrix (ES)–GBC: investor conference, 201612 supply service Sygnis AG presents at MKK Münchner Kapitalmarkt Konferenz 2016 2016-12-07
Acticor Biotech–Merck (DE): rec protein production, 201612– supply Provantage End-to-End Services for developm + manufacturing of Fab 2016-12-05
Bayer–FaunaPhotonics: digital farming technology, 201612– collab developm sensor technology for insect pest monitoring w Bayer CropScience 2016-12-05
International Phenome Centre Network–Bruker Corp: NMR technology, 201611– collab Bruker is key partner for NMR technologies + methods + SOPs 2016-12-02
Boehringer–Bruker Corp: mass spectrometer, 201612 supply of MALDI PharmaPulse 2.0 incl rapifleX MALDI-TOF System in Biberach 2016-12-01
Celgene–Evotec: drug discovery services, 201612–202111 strategic RnD collab $45m upfront using iPSC platform for drugs neurodegenerative diseases 2016-12-01
Roche–Bruker Corp: mass spectrometer, 201612 supply of MALDI PharmaPulse 2.0 incl rapifleX MALDI-TOF System to Genentech 2016-12-01
Boehringer–ACD/Labs: cheminformatics, 201611– supply deployment of ACD/Spectrus platform by Boehringer in Europe + North America 2016-11-30
Evotec–Merck (DE): target discovery technology, 201611– collab agreements to combine Merck genome editing technologies w Evotec screening (LT) 2016-11-30
Zedira–Germany (govt): grant, 201611– BMBF KMU-Innovativ funding €1.5m for 3y to support developm of ZED1227 in diabetic nephropathy 2016-11-30
AudioCure Pharma–High-Tech Gründerfonds: investment, 201611 financing round totalling €9m from new investor MED-EL + HTGF + private investors 2016-11-29
AudioCure Pharma–MED-EL: investment, 201611 financing round totalling €9m from new investor MED-EL + HTGF + private investors 2016-11-29
AudioCure Pharma–SEVERAL: investment, 201611 financing round €9m from new investor MED-EL + existing investor HTGF + private investors 2016-11-29
GeneWerk–GenoSafe: gene/cell therapy services, 201611– collab framwork agreem to offer combined research services 2016-11-29
Menarini–Chugai: cancer drug, 201611– license ww excl for class I PI3K inhibitor PA799 to Berlin-Chemie Menarini 2016-11-28
Abivax–Deutsche Börse: investor conference, 201611 supply service Abivax presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Biofrontera–Deutsche Börse: investor conference, 201611 supply service Biofrontera presents at Deutsches Eigenkapitalforum 2016 2016-11-22
BRAIN–Deutsche Börse: investor conference, 201611 supply service BRAIN AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Epigenomics–Deutsche Börse: investor conference, 201611 supply service Epigenomics AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Evotec–Deutsche Börse: investor conference, 201611 supply service Evotec AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Formycon–Deutsche Börse: investor conference, 201611 supply service Formycon AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Kiadis–Deutsche Börse: investor conference, 201611 supply service Kiadis Pharma NV presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Merck (US)–Proteros: drug discovery services, 201611– collab €na upfront + research funding + $167m milestones + royalties r+d small mol cancer drug 2016-11-22
Mologen–Deutsche Börse: investor conference, 201611 supply service Mologen AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Newron–Deutsche Börse: investor conference, 201611 supply service Newron Pharmaceuticals presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Nicox–Deutsche Börse: investor conference, 201611 supply service Nicox SA presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Paion–Deutsche Börse: investor conference, 201611 supply service Paion AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
Stratec–Deutsche Börse: investor conference, 201611 supply service Stratec Biomedical AG presents at Deutsches Eigenkapitalforum 2016 2016-11-22
4SC–Deutsche Börse: investor conference, 201611 supply service 4SC presents at Deutsches Eigenkapitalforum 2016 2016-11-21
Affimed–Deutsche Börse: investor conference, 201611 supply service Affimed presents at Deutsches Eigenkapitalforum 2016 2016-11-21
Ergomed–Deutsche Börse: investor conference, 201611 supply service Ergomed plc presents at Deutsches Eigenkapitalforum 2016 2016-11-21
Erytech–Deutsche Börse: investor conference, 201611 supply service Erytech Pharma SA presents at Deutsches Eigenkapitalforum 2016 2016-11-21
Genetrix (ES)–Deutsche Börse: investor conference, 201611 supply service Sygnis AG presents at Deutsches Eigenkapitalforum 2016 2016-11-21
MorphoSys–Deutsche Börse: investor conference, 201611 supply service MorphoSys AG presents at Deutsches Eigenkapitalforum 2016 2016-11-21
Probiodrug–Deutsche Börse: investor conference, 201611 supply service Probiodrug AG presents at Deutsches Eigenkapitalforum 2016 2016-11-21
TxCell–Deutsche Börse: investor conference, 201611 supply service TxCell SA presents at Deutsches Eigenkapitalforum 2016 2016-11-21
Valneva–Deutsche Börse: investor conference, 201611 supply service Valneva SE presents at Deutsches Eigenkapitalforum 2016 2016-11-21
Vaximm–Deutsche Börse: investor conference, 201611 supply service Vaximm participates at Deutsches Eigenkapitalforum 2016 2016-11-21
Wilex–Deutsche Börse: investor conference, 201611 supply service Wilex AG presents at Deutsches Eigenkapitalforum 2016 2016-11-21
Evotec–Leucadia: investor conference, 201611 supply service Evotec AG presents at Jefferies 2016 Global Healthcare Conference London 2016-11-17
Affimed–Leucadia: investor conference, 201611 supply service Affimed presents at Jefferies 2016 London Healthcare Conference 2016-11-16
Epigenomics–Cathay Fortune: investment, 201611 private placement €2.1m w 474.8k new shares at €4.52/share fully subscribed by Cathay Fortune 2016-11-16
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page



Advertisement

Picture [LSF] Life-Sciences-France.com – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px